05/16/2025 10:21
Cinemo’s CarPlay Ultra Integration for OEMs Accelerates Worldwide Market Adoption

Cinemo, a global leader in high-performance and automotive-grade multimedia playback, streaming, media management, connectivity, and cloud middleware, announces full integration of CarPlay Ultra via Cinemo’s CORE™ Projection — available on any automotive SoC and OS, including Android, Linux, and QNX. Cinemo’s CarPlay Ultra implementation with CORE Projection supports the full suite of CarPlay Ultra features — all the driver’s screens, including cluster display, center displays, and HUDs — and ...

05/16/2025 10:30
IFF Announces Early Tender Results and Increase of Tender Offers for Certain Outstanding Series of Notes

IFF (NYSE: IFF) announced today the early tender results for its tender offers to purchase for cash certain of its outstanding series of Notes. IFF also announced it has increased the previously announced Pool 1 Maximum Amount (as defined below) from $1,000,000,000 to $1,100,000,000 (the “Amended Pool 1 Maximum Amount”), the Pool 2 Maximum Amount (as defined below) from $800,000,000 to $900,000,000 (the “Amended Pool 2 Maximum Amount”, and together with the Amended Pool 1 Maximum Amount, the “...

05/16/2025 10:47
The smarter E Europe 2025: Studies, Technologies and Market Trends for the Energy System of Tomorrow

Exactly one week has passed since The smarter E Europe closed its doors in Munich. Once again, Europe’s largest alliance of exhibitions for the energy industry turned the Bavarian capital into the epicenter of the global energy sector and impressed with outstanding results. Over the course of three days, 2,737 exhibitors from 57 countries showcased their technologies, business models and market-ready solutions for an intelligent, interconnected and fully renewable energy system. Around 107,000 ...

05/13/2025 05:00
Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders

Azafaros, a clinical-stage company focused on developing disease-modifying therapeutics to offer new treatment options to patients with rare lysosomal storage disorders, announces the completion of an oversubscribed €132M Series B financing led by Jeito Capital, co-led by Forbion Growth and with additional participation from Seroba, Pictet Group and existing investors Forbion Ventures, Schroders Capital and BioGeneration Ventures (BGV). This financing enables Azafaros to accelerate the develop...